Quarterly report pursuant to Section 13 or 15(d)

Debt - Additional Information (Detail)

v2.4.0.8
Debt - Additional Information (Detail) (USD $)
0 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 0 Months Ended 0 Months Ended
Sep. 30, 2013
Sep. 30, 2013
Sep. 30, 2013
Sep. 30, 2014
Jun. 20, 2006
Dec. 31, 2010
Series E-1 Preferred [Member]
Jul. 31, 2009
Series C-1 Preferred [Member]
Feb. 28, 2009
Series C-1 Preferred [Member]
Jan. 31, 2012
Series C-1 Preferred [Member]
As Amended [Member]
Mar. 31, 2008
First Issuance [Member]
Sep. 30, 2008
Second Issuance [Member]
Feb. 28, 2009
Third Issuance [Member]
Jul. 31, 2013
Third Issuance [Member]
As Amended [Member]
Mar. 31, 2013
Third Issuance [Member]
As Amended [Member]
Jan. 31, 2012
Third Issuance [Member]
As Amended [Member]
Jul. 31, 2009
Fourth Issuance [Member]
Jul. 31, 2013
Fourth Issuance [Member]
As Amended [Member]
Mar. 31, 2013
Fourth Issuance [Member]
As Amended [Member]
Jan. 31, 2012
Fourth Issuance [Member]
As Amended [Member]
Sep. 30, 2013
Facility Loan Agreement [Member]
Sep. 30, 2013
Facility Loan Agreement [Member]
Sep. 30, 2013
Facility Loan Agreement [Member]
First Tranche [Member]
Sep. 30, 2013
Facility Loan Agreement [Member]
Scenario one, conversion basis [Member]
Second Tranche [Member]
Sep. 30, 2013
Facility Loan Agreement [Member]
Scenario two [Member]
Second Tranche [Member]
Wall Street Journal Prime Rate [Member]
Sep. 30, 2013
Warrants, Exercise price of $5.00 per share [Member]
Debt Instrument [Line Items]                                                  
Maximum borrowing capacity   $ 10,000,000 $ 10,000,000   $ 30,000,000                               $ 10,000,000        
Notes issued                   3,500,000 10,500,000 7,000,000       6,700,000                  
Maturity date of debt                   Mar. 17, 2011 Sep. 17, 2011 Feb. 28, 2012 Dec. 31, 2013 Aug. 01, 2013 Mar. 01, 2013 Jul. 31, 2012 Dec. 31, 2013 Aug. 01, 2013 Mar. 01, 2013            
Facility loan, fixed interest rate                   7.57% 7.57% 4.42%     4.919% 4.96%     5.46%       8.75%    
Conversion price           $ 232.93 $ 438.84 $ 438.84 $ 292.56                                
Interest expense   200,000 600,000                                            
Loan facility, outstanding principal and accrued interest settled 16,900,000                                                
Loan facility extinguished in exchange of common stock 624,944                                                
Facility loan, drawn     4,853,000                                 5,000,000          
Facility loan, interest amortization period                                       36 months          
Facility loan, final interest payment                                         300,000        
Facility loan, financial covenants                                       Until positive Phase 2b data is achieved, the Company must be in compliance with one of two financial covenants at all times (1) maintain 1.3 times cash to outstanding debt or (2) maintain sufficient cash on hand to support eight months of operations based on a trailing average monthly cash burn.          
Facility loan, fixed interest rate                                           8.75%      
Facility loan, prime rate plus                                               4.25%  
Facility fee                                       1.00%          
Warrants issued                                                 121,739
Exercise price                                                 $ 5.00
Long term warrant liability       $ 400,000                                         $ 500,000